NIDA-NIAAA 2019 Mini-Convention: Frontiers in Addiction Research

Media Advisory

Society for Neuroscience satellite meeting explores notable research on drug and alcohol addiction

Image
the 2019 Society for Neuroscience annual meeting

What: The National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), both part of the National Institutes of Health, will host a one-day mini-convention, a satellite event of the 2019 Society for Neuroscience (SfN) annual meeting. Researchers will present information on the latest technological developments in the field of addiction; novel insights for substance use disorder translational research; and use of genome editing to research substance use disorders.

Why: Scientists from around the world explore and discuss the latest research in the field of addiction neuroscience.

When: Friday, October 18, 2019
8:30 a.m. – 5:30 p.m. CDT

Where: Marriott Marquis Chicago, IL
Grand Lakes Ballroom E & F
2121 S Prairie Ave
Chicago, IL 60616

Media Registration is Free. Please register here.

NIDA-NIAAA Mini-Convention: Frontiers in Addiction Research Event Highlights:

  • Introduction and Opening Remarks (8:30-8:40 a.m.) — remarks by NIDA Director Dr. Nora D. Volkow and NIAAA Director Dr. George F. Koob.
  • Session I: Sensing New Opportunities for Addiction Neuroscience (8:40-10:10 a.m.)
  • Keynote Presentation of the 2019 Society for Neuroscience Jacob P. Waletzky Memorial Award Winner (10:20-11:30 a.m.) — keynote speech from this year’s scientist recognized for innovative research on substance use or addiction, and the nervous system. Past-year awardees can be found on the Society for Neuroscience Jacob P. Waletzky Memorial Award page.
  • NIDA-NIAAA Early Career Investigator Showcase (11:30 a.m.–1:00 p.m.) — an opportunity for early-career investigators to discuss their research findings and interests with NIDA and NIAAA staff, training directors and other substance use researchers.
  • Session II: Novel Technologies and Innovative Approaches for Translational Research Targeting Substance Use Disorders (2:15-3:45 p.m.)
  • Session III: Rewriting Genes by CRISPR for Substance Dependence and Psychiatric Disorder Research (3:55– 5:25 p.m.) 
    • NIDA Presenter: Brandon K. Harvey, Ph.D.,
      Abstract: Genome Editing in the Adult Rat Brain

NIDA at SfN Annual Meeting Highlights:

For more information on the NIDA-NIAAA Mini-Convention, visit Frontiers in Addiction ResearchFor more information on the 2019 Society for Neuroscience Annual Meeting, held October 19-23, please visit the website of the Society for Neuroscience.

NIDA Press Office
301-443-6245
media@nida.nih.gov

About the National Institute on Drug Abuse (NIDA): NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. For more information about NIDA and its programs, visit www.drugabuse.gov.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH…Turning Discovery Into Health®